You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring, and Novel Technologies
94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021386023
Dec 202113408
Jan 2022146011
Feb 20229205
Mar 202276006
Apr 202215206
May 2022132016
Jun 20229805
Jul 20224801
Aug 20229606
Sep 20224207
Oct 20225703
Nov 20224406
Dec 20226603
Jan 20233403
Feb 20232403
Mar 20232803
Apr 20231201
May 20231606
Jun 20231001
Jul 20231208
Aug 20231202
Sep 20232403
Oct 20232403
Nov 20235206
Dec 202362010
Jan 20242802
Feb 20242003
Mar 20242005
Total26310165